-
Signature
-
/s/ Bruce Jacobs, as Attorney-in-Fact
-
Issuer symbol
-
KYMR
-
Transactions as of
-
02 Mar 2026
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
04 Mar 2026, 18:00:03 UTC
Quoteable Key Fact
"Nello Mainolfi filed Form 4 for Kymera Therapeutics, Inc. (KYMR) on 04 Mar 2026."
Quick Takeaways
- This page summarizes Nello Mainolfi's Form 4 filing for Kymera Therapeutics, Inc. (KYMR).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 04 Mar 2026, 18:00.
What Changed
- Previous filing in this sequence was filed on 25 Feb 2026.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Mainolfi Nello |
Chief Executive Officer, Director |
C/O KYMERA THERAPEUTICS, INC., 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN |
/s/ Bruce Jacobs, as Attorney-in-Fact |
04 Mar 2026 |
0001821189 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
KYMR |
Stock Option (Right to Buy) |
Award |
|
+215,000 |
|
$0.000000* |
215,000 |
02 Mar 2026 |
Common Stock |
215,000 |
$90.10 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: